Antipsychotic compounds differentially modulate high-frequency oscillations in the rat nucleus accumbens: A comparison of first- and second-generation drugs

International Journal of Neuropsychopharmacology

Volumn 16, Issue 5, 2013, Pages 1009-1020

  Olszewski, MacIej ^a   Piasecka, Joanna ^a   Goda, Sailaja A ^a   Kasicki, Stefan ^a   Hunt, Mark J ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Antipsychotic drugs; high frequency oscillations; local field potential; NMDAR; nucleus accumbens

Indexed keywords

CLOZAPINE; DIZOCILPINE; HALOPERIDOL; KETAMINE; RISPERIDONE; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; HIGH FREQUENCY OSCILLATION; LOCOMOTION; MALE; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BIOLOGICAL CLOCKS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID ANTAGONISTS; KETAMINE; LOCOMOTION; MALE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; SCHIZOPHRENIA; TIME FACTORS;

EID: 84877977118     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145712001034     Document Type: Article

References (59)

1. Abdul-Monim Z, Reynolds GP, Neill JC (2003). The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. Journal of Psychopharmacology 17, 57-65.
2. Abdul-Monim Z, Reynolds GP, Neill JC (2006). The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm. Behavioural Brain Research 169, 263-273.
3. Adriani W, Felici A, Sargolini F, Roullet P, et al. (1998). N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes. Experimental Brain Research 123, 52-59.
4. Amitai N, Semenova S, Markou A (2007). Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats. Psychopharmacology (Berlin) 193, 521-537.
5. Anand A, Charney DS, Oren DA, Berman RM, et al. (2000). Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Archives of General Psychiatry 57, 270-276.
6. Baker RW, Chengappa KN, Baird JW, Steingard S, et al. (1992). Emergence of obsessive compulsive symptoms during treatment with clozapine. Journal of Clinical Psychiatry 53, 439-442.
7. Bakshi VP, Swerdlow NR, Geyer MA (1994). Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. Journal of Pharmacology and Experimental Therapeutics 271, 787-794.
8. Callaway CW, Hakan RL, Henriksen SJ (1991). Distribution of amygdala input to the nucleus accumbens septi: an electrophysiological investigation. Journal of Neural Transmission 83, 215-225.
9. Cohen MX, Axmacher N, Lenartz D, Elger CE, et al. (2009). Good vibrations: cross-frequency coupling in the human nucleus accumbens during reward processing. Journal of Cognitive Neuroscience 21, 875-889.
10. Freed WJ, Bing LA, Wyatt RJ (1984). Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice. Neuropharmacology 23, 175-181.
11. French SJ, Totterdell S (2002). Hippocampal and prefrontal cortical inputs monosynaptically converge with individual projection neurons of the nucleus accumbens. Journal of Comparative Neurology 446, 151-165.
12. French SJ, Totterdell S (2003). Individual nucleus accumbens-projection neurons receive both basolateral amygdala and ventral subicular afferents in rats. Neuroscience 119, 19-31.
13. Grace AA (2000). Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Research Reviews 31, 330-341.
14. Grayson B, Idris NF, Neill JC (2007). Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Behavioural Brain Research 184, 31-38.
15. Hakami T, Jones NC, Tolmacheva EA, Gaudias J, et al. (2009). NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness. PLoS One 4, e6755.
16. Homayoun H, Moghaddam B (2007). Fine-tuning of awake prefrontal cortex neurons by clozapine: comparison with haloperidol and N-desmethylclozapine. Biological Psychiatry 61, 679-687.
17. Hong LE, Summerfelt A, Buchanan RW, O'Donnell P et al. (2010). Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Neuropsychopharmacology 35, 632-640.
18. Hunt MJ, Falinska M, Kasicki S (2010). Local injection of MK801 modifies oscillatory activity in the nucleus accumbens in awake rats. Journal of Psychopharmacology 24, 931-941.
19. Hunt MJ, Falinska M, Leski S, Wojcik DK, Kasicki S (2011). Differential effects produced by ketamine on oscillatory activity recorded in the rat hippocampus, dorsal striatum and nucleus accumbens. Journal of Psychopharmacology 25, 808-821.
20. Hunt MJ, Garcia R, Large CH, Kasicki S (2008). Modulation of high-frequency oscillations associated with NMDA receptor hypofunction in the rodent nucleus accumbens by lamotrigine. Progress in Neuropsychopharmacology and Biological Psychiatry 32, 1312-1319.
21. Hunt MJ, Matulewicz P, Gottesmann C, Kasicki S (2009). State-dependent changes in high-frequency oscillations recorded in the rat nucleus accumbens. Neuroscience 164, 380-386.
22. Hunt MJ, Raynaud B, Garcia R (2006). Ketamine dose-dependently induces high-frequency oscillations in the nucleus accumbens in freely moving rats. Biological Psychiatry 60, 1206-1214.
23. Idris NF, Repeto P, Neill JC, Large CH (2005). Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat. Psychopharmacology (Berlin) 179, 336-348.
24. Jones NC, Reddy M, Anderson P, Salzberg MR, et al. (2012). Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power. International Journal of Neuropsychopharmacology 15, 657-668.
25. Kinon BJ, Lieberman JA (1996). Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology (Berlin) 124, 2-34.
26. Kuroki T, Nagao N, Nakahara T (2008). Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Progress in Brain Research 172, 199-212.
27. Lee KH, Williams LM, Breakspear M, Gordon E (2003). Synchronous gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia. Brain Research Reviews 41, 57-78.
28. Lykouras L, Alevizos B, Michalopoulou P, Rabavilas A (2003). Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Progress in Neuropsychopharmacology and Biological Psychiatry 27, 333-346.
29. Ma J, Leung LS (2000). Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine. Behavioural Brain Research 111, 1-11.
30. Martin P, Svensson A, Carlsson A, Carlsson ML (1994). On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801. Journal of Neural Transmission 95, 113-121.
31. Matulewicz P, Kasicki S, Hunt MJ (2010). The effect of dopamine receptor blockade in the rodent nucleus accumbens on local field potential oscillations and motor activity in response to ketamine. Brain Research 1366, 226-232.
32. Meltzer HY, Huang M (2008). In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Progress in Brain Research 172, 177-197.
33. i values. Journal of Pharmacology and Experimental Therapeutics 251, 238-246.
34. Mielke DH, Gallant DM, Kessler C (1977). An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels. American Journal of Psychiatry 134, 1371-1375.
35. Miyamoto S, Duncan GE, Marx CE, Lieberman JA (2005). Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Molecular Psychiatry 10, 79-104.
36. Neill JC, Barnes S, Cook S, Grayson B, et al. (2010). Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacology and Therapeutics 128, 419-432.
37. Nicolas MJ, Lopez-Azcarate J, Valencia M, Alegre M, et al. (2011). Ketamine-induced oscillations in the motor circuit of the rat basal ganglia. PLoS One 6, e21814.
38. O'Donnell P, Grace AA (1995). Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. Journal of Neuroscience 15, 3622-3639.
39. Olney JW, Newcomer JW, Farber NB (1999). NMDA receptor hypofunction model of schizophrenia. Journal of Psychiatric Research 33, 523-533.
40. Paine TA, Carlezon Jr. WA (2009). Effects of antipsychotic drugs on MK-801-induced attentional and motivational deficits in rats. Neuropharmacology 56, 788-797.
41. Passetti F, Levita L, Robbins TW (2003). Sulpiride alleviates the attentional impairments of rats with medial prefrontal cortex lesions. Behavioural Brain Research 138, 59-69.
42. Paxinos W, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Waltham, MA: Academic Press.
43. Phillips KG, Cotel MC, McCarthy AP, Edgar DM, et al. (2012). Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia. Neuropharmacology 62, 1359-1370.
44. Pinault D (2008). N-methyl D-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biological Psychiatry 63, 730-735.
45. Rao VA, Bailey J, Bishop M, Coppen A (1981). A clinical and pharmacodynamic evaluation of sulpiride. Psychopharmacology (Berlin) 73, 77-80.
46. Sa AR, Hounie AG, Sampaio AS, Arrais J, et al. (2009). Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol. Comprehensive Psychiatry 50, 437-442.
47. Sams-Dodd F (1998). Effects of dopamine agonists and antagonists on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test. Psychopharmacology (Berlin) 135, 182-193.
48. Sams-Dodd F (1999). Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Reviews in the Neurosciences 10, 59-90.
49. Santana N, Troyano-Rodriguez E, Mengod G, Celada P, et al. (2011). Activation of thalamocortical networks by the N-methyl-D-aspartate receptor antagonist phencyclidine: reversal by clozapine. Biological Psychiatry 69, 918-927.
50. Schwabe K, Brosda J, Wegener N, Koch M (2005). Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine-or phencyclidine-treatment in Wistar rats. Pharmacology, Biochemistry and Behavior 80, 213-219.
51. Seeman P (2002). Atypical antipsychotics: mechanism of action. Canadian Journal of Psychiatry 47, 27-38.
52. Seeman P, Chau-Wong M, Tedesco J, Wong K (1975). Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proceedings of the National Academy of Sciences USA 72, 4376-4380.
53. Spencer KM (2011). Baseline gamma power during auditory steady-state stimulation in schizophrenia. Frontiers in Human Neuroscience 5, 190.
54. Sturm V, Lenartz D, Koulousakis A, Treuer H, Herholz K, et al. (2003). The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive-and anxiety-disorders. Journal of Chemical Neuroanatomy 26, 293-299.
55. Tiedtke PI, Bischoff C, Schmidt WJ (1990). MK-801-induced stereotypy and its antagonism by neuroleptic drugs. Journal of Neural Transmission 81, 173-182.
56. Uhlhaas PJ, Singer W (2010). Abnormal neural oscillations and synchrony in schizophrenia. Nature Reviews Neuroscience 11, 100-113.
57. Weiner I, Arad M (2009). Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment. Behavioural Brain Research 204, 369-386.
58. Venables NC, Bernat EM, Sponheim SR (2009). Genetic and disorder-specific aspects of resting state EEG abnormalities in schizophrenia. Schizophrenia Bulletin 35, 826-839.
59. Zhang Y, Llinas RR, Lisman JE (2012). NMDAR antagonist action in thalamus imposes delta oscillations on the hippocampus. Journal of Neurophysiology 107, 3181-3189.